Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights Microsoft, Amazon.com, Berkshire Hathaway, Abbott and BlackRock

by Zacks Equity Research

Microsoft, Amazon.com, Berkshire Hathaway, Abbott and BlackRock are included in this Analyst Blog.

Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know

by Zacks Equity Research

In the most recent trading session, Abbott (ABT) closed at $119.02, indicating a +0.98% shift from the previous trading day.

Mark Vickery headshot

Top Analyst Reports for Microsoft, Amazon.com & Berkshire Hathaway

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amazon.com, Inc. (AMZN) and Berkshire Hathaway Inc. (BRK.B).

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for PJP

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for NOBL

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Insulet's (PODD) Omnipod 5 Gets CE Mark for Added Compatibility

by Zacks Equity Research

Insulet's (PODD) tubeless automated insulin delivery system's CE mark approval with multiple CGM sensor brands is likely to serve a wider patient pool.

HAE vs. ABT: Which Stock Is the Better Value Option?

by Zacks Equity Research

HAE vs. ABT: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Research Reports for Abbott, T-Mobile & Booking

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Abbott (ABT) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.

Manufacturing Numbers Expected After Opening Bell

by Zacks Equity Research

Manufacturing Numbers Expected After Opening Bell.

Abbott's (ABT) Q4 Earnings Match Estimates, Margins Rise

by Zacks Equity Research

Abbott (ABT) delivers better-than-expected revenues and in-line earnings for the fourth quarter of 2023.

Mark Vickery headshot

Q4 Earnings Roundup: ABT, GD, KMB & More

by Mark Vickery

A spot-check of early morning Q4 reports show some earnings misses and revenue beats; Tesla and others report after the close.

Here's What Key Metrics Tell Us About Abbott (ABT) Q4 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Abbott (ABT) Q4 Earnings Match Estimates

by Zacks Equity Research

Abbott (ABT) delivered earnings and revenue surprises of 0% and 0.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Shaun Pruitt headshot

Top Stocks to Watch as Earnings Approach

by Shaun Pruitt

Several expansive companies are expected to post stellar quarterly growth when they report Q4 results on Wednesday, January 24.

What's in Store for Zimmer Biomet (ZBH) in Q4 Earnings?

by Zacks Equity Research

Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter.

Should You Buy Abbott Laboratories (ABT) Ahead of Earnings?

by Zacks Equity Research

Abbott Laboratories (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

CVS Health (CVS) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

CVS Health's (CVS) fourth-quarter 2023 results are likely to reflect the strength of the Pharmacy & Consumer Wellness and Health Services segments.

Seeking Clues to Abbott (ABT) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

If You Invested $1000 in Abbott 10 Years Ago, This Is How Much You'd Have Now

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

Abbott (ABT) concluded the recent trading session at $114.02, signifying a +0.08% move from its prior day's close.